Highlights Commencement of U.S. Regulatory Process CLEO has completed an initial pre-submission meeting with the U.S. Food and Drug Administration (FDA) where the Company outlined its submission framework and clinical plan for its ovarian cancer detection blood test. The pre-submission meeting is designed to permit CLEO to receive early guidance from FDA review teams prior...
Category: investingnews
Strong Intercepts Confirm Significant Production Potential at Gould’s Dam
Highlights These results support the Company’s strategy to increase the nameplate production rate and mine life at its 100 per cent-owned Honeymoon Uranium Mine in South Australia. In light of these strong results, work has commenced on accelerating the development of Gould’s Dam, which is an important satellite project to the nearby Honeymoon Mine. The...
Sarama Completes Tranche 1 Equity Placement and ASX Cleansing Notice
Tranche 1 of the Placement raised aggregate gross proceeds of A$900,000 with the Company issuing 45,000,000 Chess Depository Instruments (“CDIs”) at an issue price of A$0.02 per CDI. Each new CDI issued under the Placement will rank equally with existing CDIs on issue and each CDI will represent a beneficial interest in one common share...
Vizsla Copper Begins Drilling at Woodjam Copper-Gold Property
“With our financing freshly closed, I’m excited about the start of drilling at Woodjam,” commented Craig Parry, Executive Chairman. “Strong copper prices are expected to continue over the long term and Vizsla Copper is executing on its strategy of acquiring undervalued copper assets and completing selective, high-impact exploration programs on our best targets.“ “Well mineralized...
Quetzal Copper Announces Resumption of Trading
The Company also announces that it will cancel the previously announced $2,000,000 non-brokered private placement at this time. About Quetzal Copper Quetzal is engaged in the acquisition, exploration, and development of mineral properties in British Columbia and Mexico. Quetzal currently has a portfolio of three properties located in British Columbia, Canada and one in Mexico....
Principal Technologies Announces Extension of Private Placement Closing Date
ON BEHALF OF THE BOARD Jerry Trent, Chief Executive Officer Principal Technologies Inc. For investor inquiries or further information, please contact: Office@principal-technologies.com Forward-looking statements: This press release contains “forward-looking information” and “forward-looking statements” within the meaning of applicable securities laws. This information and statements address future activities, events, plans, developments and projections. All statements, other...
Expressions of Interest Submitted
Highlights: A third RFI submitted relates to the exploration licences CTL holds in the basin of the Salar de Atacama, which are significantly outside the salar margin, and the area designated as strategic under the National Lithium Strategy. This has been designated as the ´Arenas Blancas´ project. The Company has submitted a joint venture RFI...
Zodiac Gold Completes Pre-Drilling Satellite Data Interpretation at the Alasala Target on the Todi Gold Project
Management Commentary David Kol, CEO, commented, “Completing this satellite data interpretation study marks a significant step forward in our exploration efforts at the Alasala target. The detailed insights into the geological setting and the identification of new structural trends improve our understanding of the controls on mineralization and enhance our confidence in the potential for...
Keith Weiner: US$2,700 Gold, US$36 Silver? Modeling Fundamental Prices
Speaking to the Investing News Network, Keith Weiner, founder and CEO of Monetary Metals, discussed the factors driving gold and silver prices right now and what could be in store for the precious metals in the future. Breaking down macroeconomics, monetary policy and supply/demand, he explained why he sees both moving higher. “I think the...
Radiopharm Theranostics Completes A$70 Million Placement
As part of the Placement, as announced on 20 June 2024 and subject to shareholder approval, Lantheus has subscribed for: Riccardo Canevari, Radiopharm’s Chief Executive Officer & Managing Director, said “We are delighted to complete this significant capital raise which will allow us to accelerate the development of our portfolio, as well as provide an...